Researchers at the Boyce Thompson Institute and John Hopkins University discovered that salicylic acid, the primary breakdown product of aspirin, binds to GAPDH, thereby stopping it from moving into a cell's nucleus, where it can trigger the cell's death. (GAPDH is an enzyme; MitoSciences: Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) ). The study, which appears in the journal PLOS ONE, also suggests that derivatives of salicylic acid may hold promise for treating multiple neurodegenerative diseases. Diseases such as Parkinson's, Huntington's, and Alzheimer's.
Anyways, you can read about it here: A breakdown product of aspirin blocks cell death associated with Alzheimer's, Parkinson's and Huntington's diseases
Anyways, you can read about it here: A breakdown product of aspirin blocks cell death associated with Alzheimer's, Parkinson's and Huntington's diseases